Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F3PFW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,199
Award facts
- Contract value 100% obligated
- $10,199.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 17, 2025, for Xeljanz XR 11 mg tablets in a quantity of 30 units. This contract is a firm fixed-price delivery order with a ceiling value of $10,199.16 and an ultimate completion date of November 18, 2025. The award was competitively procured without a set-aside designation. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Department of Defense and federal healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, vaccines, specialty medications, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contractor's extensive portfolio of federal contract awards demonstrates consistent capability to meet government procurement requirements through competitive processes, with pricing flexibility across transaction sizes and product categories. This delivery order for Xeljanz XR, a rheumatoid arthritis medication, exemplifies the routine pharmaceutical supply fulfillment that AmerisourceBergen provides through its established federal contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F3PFW?
SPE2DR26F3PFW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F3PFW worth?
The government has obligated $10,199 on SPE2DR26F3PFW.
Is contract SPE2DR26F3PFW an order under another contract?
Yes. SPE2DR26F3PFW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PFW competed?
The extent of competition for SPE2DR26F3PFW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award